# AIMOVIG

NDC: 55513-841
Generic name: erenumab-aooe
Labeler / Manufacturer: Amgen Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20180522

FDA application: BLA761077

## Active ingredients

- ERENUMAB: 70 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-841"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-841
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b998ed05-94b0-47fd-b28f-cddd1e128fd8